214 related articles for article (PubMed ID: 319362)
1. Enzymology of cancer cells (first of two parts).
Weber G
N Engl J Med; 1977 Mar; 296(9):486-92. PubMed ID: 319362
[No Abstract] [Full Text] [Related]
2. Clinical cell biology and cancer.
Tanneberger S
Arch Geschwulstforsch; 1972; 39(1):44-7. PubMed ID: 5029394
[No Abstract] [Full Text] [Related]
3. Cancer stem cells: a step toward the cure.
Boman BM; Wicha MS
J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956
[No Abstract] [Full Text] [Related]
4. [On the question of preclinical selection of cytostatics in the area of treatment of human tumors].
Wüst GP
Arzneimittelforschung; 1969 May; 19(5):817-9. PubMed ID: 4184536
[No Abstract] [Full Text] [Related]
5. [Cellular biology and antitumoral chemotherapy].
Lanza I
Minerva Pediatr; 1968 Jun; 20(24):1233-9. PubMed ID: 5736916
[No Abstract] [Full Text] [Related]
6. Clinical implications of tumor-cell heterogeneity.
Schnipper L
N Engl J Med; 1986 May; 314(22):1423-31. PubMed ID: 3517651
[No Abstract] [Full Text] [Related]
7. Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture.
Weber G
Cancer Res; 1983 Aug; 43(8):3466-92. PubMed ID: 6305486
[No Abstract] [Full Text] [Related]
8. Sensitivity tests on human cancers to select active drugs for clinical cancer therapy.
Knock FE; Galt RM; Oester YT; Sylvester R
S Afr J Med Sci; 1973 Dec; 38(3):43-50. PubMed ID: 4799205
[No Abstract] [Full Text] [Related]
9. Cell population kinetics and chemotherapy. I. The kinetics of tumor cell populations.
Steel GG; Lamerton LF
Natl Cancer Inst Monogr; 1969 May; 30():29-42. PubMed ID: 5351827
[No Abstract] [Full Text] [Related]
10. [Current aspects of drug therapy of cancer].
Vicente J
Rev Clin Esp; 1970 Dec; 119(6):501-16. PubMed ID: 4928318
[No Abstract] [Full Text] [Related]
11. [Testing the sensitivity of malignant tumors to cytostatics in vitro and in vivo. Methods and clinical experiences].
Wüst GP
Munch Med Wochenschr; 1973 May; 115(18):839-42. PubMed ID: 4800216
[No Abstract] [Full Text] [Related]
12. [Molecular mechanism of cell death induced by chemotherapeutic agents].
Saya H
Brain Nerve; 2009 Jul; 61(7):843-7. PubMed ID: 19618862
[TBL] [Abstract][Full Text] [Related]
13. Kinetic behavior versus response to chemotherapy.
Skipper HE
Natl Cancer Inst Monogr; 1971 Dec; 34():2-14. PubMed ID: 4946581
[No Abstract] [Full Text] [Related]
14. Effects of chemotherapy on the incorporation of 3 H-thymidine into DNA of human neoplastic tissue.
Sky-Peck HH
Natl Cancer Inst Monogr; 1971 Dec; 34():197-203. PubMed ID: 5140863
[No Abstract] [Full Text] [Related]
15. Cell senescence and cancer.
Mathon NF; Lloyd AC
Nat Rev Cancer; 2001 Dec; 1(3):203-13. PubMed ID: 11902575
[TBL] [Abstract][Full Text] [Related]
16. Alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone inhibitors of ribonucleoside diphosphate reductase.
Booth BA; Agrawal KC; Moore EC; Sartorelli AC
Cancer Res; 1974 Jun; 34(6):1308-14. PubMed ID: 4363653
[No Abstract] [Full Text] [Related]
17. The resting cell: a chemotherapeutic problem. Part I.
Sarna G
Biomedicine; 1974 Sep; 20(5):322-6. PubMed ID: 4451696
[No Abstract] [Full Text] [Related]
18. Biochemical rationales for the selection of combinations of chemotherapeutic agents.
Bono VH
Cancer Chemother Rep 2; 1974 Mar; 4(1):131-6. PubMed ID: 4826492
[No Abstract] [Full Text] [Related]
19. [Plants with cytostatic effect].
van Os FH
Farmaco Sci; 1970 Jun; 25(6):455-83. PubMed ID: 4916952
[No Abstract] [Full Text] [Related]
20. [Various aspects of the problem of selectivity in the chemotherapy of cancer].
Velousova AK
Vopr Onkol; 1969; 15(8):96-110. PubMed ID: 4901626
[No Abstract] [Full Text] [Related]
[Next] [New Search]
